Intelligent Gross Profit Margin from 2010 to 2024

INBS Stock  USD 1.60  0.03  1.84%   
Intelligent Bio Gross Profit Margin yearly trend continues to be comparatively stable with very little volatility. Gross Profit Margin will likely drop to 0.29 in 2024. From the period from 2010 to 2024, Intelligent Bio Gross Profit Margin quarterly data regression had r-value of  0.44 and coefficient of variation of  18.62. View All Fundamentals
 
Gross Profit Margin  
First Reported
2010-12-31
Previous Quarter
0.45813828
Current Value
0.29
Quarterly Volatility
0.05121826
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Intelligent Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Intelligent Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.4 M, Interest Expense of 158.8 K or Selling General Administrative of 4.9 M, as well as many indicators such as Price To Sales Ratio of 0.89, Dividend Yield of 0.0 or PTB Ratio of 0.37. Intelligent financial statements analysis is a perfect complement when working with Intelligent Bio Valuation or Volatility modules.
  
Check out the analysis of Intelligent Bio Correlation against competitors.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Intelligent Stock Analysis

When running Intelligent Bio's price analysis, check to measure Intelligent Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intelligent Bio is operating at the current time. Most of Intelligent Bio's value examination focuses on studying past and present price action to predict the probability of Intelligent Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intelligent Bio's price. Additionally, you may evaluate how the addition of Intelligent Bio to your portfolios can decrease your overall portfolio volatility.